67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 221 / Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02115659 (ClinicalTrials.gov)	April 2014	14/4/2014	Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Randomized Controlled Trial of Triptolide-Containing Formulation for Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Drug: Triptolide -Containing Formulation;Drug: Placebo	Shanghai Changzheng Hospital	NULL	Recruiting	40 Years	75 Years	Both	100	Phase 3	China
2	ChiCTR-TRC-11001282	2011-04-01	2011-04-21	Triptolide Retards Autosomal Dominant Polycystic Kidney Disease with Proteinuria	Triptolide Retards Autosomal Dominant Polycystic Kidney Disease with Proteinuria	Autosomal dominant polycystic kidney disease;Q61.301	Group A:Glucosidorum Tripterygll Totorum+losartan potassium ;Group B:Placebo + losartan potassium;	Shanghai Changzheng Hospital	NULL	Completed	18	55	Both	Group A:30;Group B:30;		China
3	NCT00801268 (ClinicalTrials.gov)	November 2008	25/11/2008	Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease	Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Polycystic Kidney	Drug: tripterygium wilfordii;Drug: Emodin	Zhi-Hong Liu, M.D.	NULL	Terminated	15 Years	70 Years	Both	300	N/A	China